Allowing Online Sale of Medicines Is the Need of the Hour: Empower India

Business Wire IndiaIndia has been established as a superpower in many sectors, including space, which is known to be the bastion of few advanced nations. Expected to emerge as the third largest economy by 2030, India is one of the fastest adopters of technology (1.2B+ mobile subscribers, over 10B monthly digital payments, and third largest startup ecosystem). While sectors like agriculture, education and retail are benefitting from the technology enabled boom, the healthcare sector is yet to make use of this untapped potential.
The Indian healthcare sector still is dependent on the brick & mortar approach of allowing access to medicines through physical shops only. According to a report by Copenhagen Economics, 57% of respondents in the EU who used online dispensing services believe that such access helps improve adherence to medication. 80% also said that they prefer home delivery, and more than 65% of pharmacy owners from France, Italy, and Spain are willing to sell online if government restrictions on online access to prescription of medicines are lifted.
Mr. K. Giri, Secretary General, Empower India underscored the importance of adoption of e-pharmacy stating, “In an era where digital solutions are transforming ways of living, Indian regulators must incentivize offline pharmacy stores to sell medicines through e-commerce. This will not only increase their earning but also result in access to prescribed medicines at a uniform rate for the consumers. Drawing inspiration from Europe’s achievements, India can spearhead its evolution towards a more accessible and patient-centric healthcare landscape.”
He added, “E-pharmacy has proven to be a boon for patients globally, and India stands to gain immensely by embracing this modern healthcare solution. However, to leverage these advantages, regulatory bodies must adopt flexible policies that facilitate seamless purchasing of online medicine and prescriptions. Similar to Europe, India’s policymakers should implement adaptable regulatory frameworks that promote e-pharmacy growth while safeguarding patient interests.
India’s e-pharmacy market is expected to reach INR 89.47 Bn by 2027, showcasing immense potential for both conventional e-commerce platforms and brick-and-mortar stores to capitalize on this burgeoning sector. E-commerce platforms are catering to consumer demands by offering a streamlined experience and end-to-end solutions that save time and provide flexibility. The availability of prescribed salt at a uniform price, convenience of ordering medicines from remote locations and arrangements for a specialist discussion (E-counsel) will be driving factors for the same.
While e-pharmacy still contributes to over 70% of the overall revenue for digital health players, there is an increased focus on building a broader digital health offering – teleconsultation, diagnostics, care packages, and surgery assistance. Still being at a nascent stage, ‘Digital Health’ can help India bridge the health divide by eliminating geographical constraints in the supply (providers) and demand (patients) construct. For instance, a customer living in the small town of Asansol can consult a pediatrician in Delhi within minutes and a customer in Kapurthala can conveniently get doorstep delivery of medicines which are unavailable in her town. Moreover, patients with physical conditions or illnesses can order medicines whenever they need with the round-the-clock access of online pharmacies.